Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial.
Georg GelbeneggerUlrich JaegerMichael FillitzShirley D'SaRonwyn CartwrightFrank ShaferMarek WardȩckiJennifer WangChristian SchoergenhoferBernd JilmaPublished in: British journal of haematology (2022)